BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8196451)

  • 21. [Differentiated thyroid carcinoma: prognostic factors].
    Györy F; Lukács G; Nagy EV; Juhász F; Mezösi E; Szakáll S; Máth J; Balázs G
    Magy Seb; 2001 Apr; 54(2):69-74. PubMed ID: 11339092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cause of death in patients with well-differentiated thyroid carcinoma.
    Beasley NJ; Walfish PG; Witterick I; Freeman JL
    Laryngoscope; 2001 Jun; 111(6):989-91. PubMed ID: 11404609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients.
    Volante M; Landolfi S; Chiusa L; Palestini N; Motta M; Codegone A; Torchio B; Papotti MG
    Cancer; 2004 Mar; 100(5):950-7. PubMed ID: 14983490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diffuse sclerosing variant of papillary carcinoma of the thyroid: a 35-year comparative study at a single institution.
    Lam AK; Lo CY
    Ann Surg Oncol; 2006 Feb; 13(2):176-81. PubMed ID: 16411146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Papillary carcinoma of the thyroid. Analysis of survival in 186 cases].
    Solaini L; Turicchia GU; Bagioni P; Stancanelli V; Riva P; Paganelli G; Agostini M; Cacciaguerra G; Gentili G
    Minerva Chir; 1985 May; 40(9):627-34. PubMed ID: 4034008
    [No Abstract]   [Full Text] [Related]  

  • 26. Prognostic factors in thyroid carcinomas.
    Fonseca E; Soares P; Rossi S; Sobrinho-Simões M
    Verh Dtsch Ges Pathol; 1997; 81():82-96. PubMed ID: 9474858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors of insular versus papillary/follicular thyroid carcinoma.
    Falvo L; Catania A; D'Andrea V; Grilli P; D'Ercole C; De Antoni E
    Am Surg; 2004 May; 70(5):461-6. PubMed ID: 15156957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of histologic grading compared with subclassification of papillary thyroid carcinoma.
    Akslen LA; LiVolsi VA
    Cancer; 2000 Apr; 88(8):1902-8. PubMed ID: 10760768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Identification and validation of prognostic factors in differentiated thyroid carcinoma].
    Gómez Arnaiz N; Gómez Sáez IM; Sahún de la Vega M; Abós R; Villabona Artero C; Soler Ramón J
    Med Clin (Barc); 1997 Jan; 108(2):45-9. PubMed ID: 9064416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiated thyroid carcinoma: comparison between papillary and follicular carcinoma in a single institute.
    Chow SM; Law SC; Au SK; Leung TW; Chan PT; Mendenhall WM; Lau WH
    Head Neck; 2002 Jul; 24(7):670-7. PubMed ID: 12112541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
    Haq M; Harmer C
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AMES, MACIS and TNM prognostic classifications in papillary thyroid carcinoma.
    Voutilainen PE; Siironen P; Franssila KO; Sivula A; Haapiainen RK; Haglund CH
    Anticancer Res; 2003; 23(5b):4283-8. PubMed ID: 14666639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma.
    Bhattacharyya N
    Otolaryngol Head Neck Surg; 2003 Jan; 128(1):115-23. PubMed ID: 12574769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Differentiated thyroid carcinoma, 1972-1992. Follow-up, detection of recurrences and prognostic factors].
    Obiols G; Simó R; Burgos R; Tresserras R; Galofré P; Masmiquel L; Hernández C; Mesa J
    Med Clin (Barc); 1997 Nov; 109(19):738-43. PubMed ID: 9470182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Differentiated thyroid cancer in Arabs in northern Israel].
    Zidan J; Kassem S; Karen D; Kuten A; Robinson E
    Harefuah; 1997 Jan; 132(1):6-9, 72. PubMed ID: 9035579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
    Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
    Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging.
    Lang BH; Lo CY; Chan WF; Lam KY; Wan KY
    Ann Surg Oncol; 2007 Feb; 14(2):730-8. PubMed ID: 17103065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical presentations and outcomes of surgical treatment of follicular variant of the papillary thyroid carcinomas.
    Chang HY; Lin JD; Chou SC; Chao TC; Hsueh C
    Jpn J Clin Oncol; 2006 Nov; 36(11):688-93. PubMed ID: 17000702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
    Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
    J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors in patients with differentiated thyroid carcinoma.
    Steinmüller T; Klupp J; Rayes N; Ulrich F; Jonas S; Gräf KJ; Neuhaus P
    Eur J Surg; 2000 Jan; 166(1):29-33. PubMed ID: 10688213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.